Pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI Listing Regulations (LODR) Regulations, 2015, Bharat Parenterals has informed that the Company has fixed 19th September, 2022 as cut-off date to enable Shareholders to exercise their right to vote by electronic means during e-voting period on all resolutions set forth in the Notice of 29th Annual General Meeting (AGM) or to vote during AGM scheduled to be held on 27th September, 2022 at 10:30 am through Video Conference (VC)/ Other Audio Visual Means (OAVM), in accordance with the relevant Circulars issued by the Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: